Energizer Holdings Valuation
Is EGG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EGG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EGG (€33) is trading below our estimate of fair value (€117.06)
Significantly Below Fair Value: EGG is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EGG?
Key metric: As EGG is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is EGG's PS Ratio? | |
|---|---|
| PS Ratio | 0.9x |
| Sales | US$2.89b |
| Market Cap | US$2.45b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.9x |
| Enterprise Value/EBITDA | 9.7x |
| PEG Ratio | 10.3x |
Price to Sales Ratio vs Peers
How does EGG's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.5x | ||
HEN3 Henkel KGaA | 1.5x | 2.9% | €30.9b |
CENT Central Garden & Pet | 0.8x | 2.8% | US$2.2b |
SPB Spectrum Brands Holdings | 0.9x | 2.0% | US$2.5b |
6993 Blue Moon Group Holdings | 2.7x | 8.5% | HK$22.6b |
EGG Energizer Holdings | 0.9x | 1.6% | €2.5b |
Price-To-Sales vs Peers: EGG is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (1.5x).
Price to Sales Ratio vs Industry
How does EGG's PS Ratio compare vs other companies in the Global Household Products Industry?
| 8 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 8 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: EGG is good value based on its Price-To-Sales Ratio (0.9x) compared to the Global Household Products industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is EGG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.9x |
| Fair PS Ratio | 1x |
Price-To-Sales vs Fair Ratio: EGG is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €33.00 | €33.66 +2.0% | 12.3% | €42.47 | €28.31 | n/a | 9 |
| Nov ’25 | €29.20 | €31.91 +9.3% | 10.1% | €36.82 | €27.62 | n/a | 9 |
| Oct ’25 | €28.20 | €30.30 +7.4% | 11.9% | €35.76 | €25.93 | n/a | 9 |
| Sep ’25 | €29.20 | €30.30 +3.8% | 11.9% | €35.76 | €25.93 | n/a | 9 |
| Aug ’25 | €28.40 | €30.19 +6.3% | 12.6% | €38.55 | €25.70 | n/a | 9 |
| Jul ’25 | €27.40 | €30.63 +11.8% | 12.4% | €39.12 | €27.01 | n/a | 9 |
| Jun ’25 | €26.20 | €30.71 +17.2% | 12.1% | €39.09 | €26.99 | n/a | 9 |
| May ’25 | €26.40 | €31.38 +18.9% | 11.5% | €39.14 | €27.03 | n/a | 9 |
| Apr ’25 | €26.80 | €32.30 +20.5% | 9.1% | €38.76 | €28.61 | n/a | 9 |
| Mar ’25 | €26.20 | €32.30 +23.3% | 9.1% | €38.76 | €28.61 | n/a | 9 |
| Feb ’25 | €29.20 | €32.85 +12.5% | 9.3% | €38.65 | €28.53 | n/a | 10 |
| Jan ’25 | €28.60 | €32.90 +15.0% | 9.0% | €38.38 | €28.33 | n/a | 10 |
| Dec ’24 | €28.20 | €32.90 +16.7% | 9.0% | €38.38 | €28.33 | n/a | 10 |
| Nov ’24 | €29.80 | €34.09 +14.4% | 8.2% | €39.89 | €31.34 | €29.20 | 10 |
| Oct ’24 | €30.40 | €34.20 +12.5% | 8.1% | €38.82 | €30.51 | €28.20 | 10 |
| Sep ’24 | €31.60 | €34.20 +8.2% | 8.1% | €38.82 | €30.51 | €29.20 | 10 |
| Aug ’24 | €32.20 | €34.86 +8.3% | 7.0% | €38.64 | €30.55 | €28.40 | 10 |
| Jul ’24 | €30.40 | €36.07 +18.6% | 7.6% | €39.56 | €31.28 | €27.40 | 10 |
| Jun ’24 | €30.20 | €35.52 +17.6% | 7.5% | €39.16 | €30.96 | €26.20 | 11 |
| May ’24 | €29.80 | €33.64 +12.9% | 8.8% | €39.10 | €30.00 | €26.40 | 11 |
| Apr ’24 | €31.00 | €35.30 +13.9% | 8.9% | €40.14 | €30.80 | €26.80 | 11 |
| Mar ’24 | €33.80 | €35.30 +4.4% | 8.9% | €40.14 | €30.80 | €26.20 | 11 |
| Feb ’24 | €33.80 | €34.67 +2.6% | 9.0% | €40.96 | €30.04 | €29.20 | 11 |
| Jan ’24 | €32.00 | €34.31 +7.2% | 11.0% | €42.45 | €28.30 | €28.60 | 11 |
| Dec ’23 | €32.40 | €35.32 +9.0% | 11.2% | €43.93 | €29.29 | €28.20 | 11 |
| Nov ’23 | €28.80 | €35.08 +21.8% | 16.0% | €46.02 | €27.61 | €29.80 | 10 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
Cheerwin Group
HK$2.6b
An investment holding company, manufactures and trades household insecticides and repellents, household cleaning, air care, personal care, pets and pet products, and other products in the People’s Republic of China.
1RQ
HK$0.22
7D
-1.8%
1Y
33.3%
Revolution Beauty Group
UK£41.0m
Engages in the development, production, wholesale, and retail of beauty products in the United Kingdom, the United States, and internationally.
8UA
UK£0.15
7D
-4.4%
1Y
-46.5%
McBride
UK£174.9m
Manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Italy, Spain, rest of Europe, Asia-Pacific, and internationally.It operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific.
10W
UK£1.24
7D
0.8%
1Y
87.9%